Generic placeholder image

Protein & Peptide Letters


ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Research Article

Expression, Purification, and in vivo Evaluation of GFP-Fused M Cell Targeting Receptor Binding Domain of Protein FimH

Author(s): Thanh-Hoa Nguyen-Thi, Kien-Quang Huynh, Phuong-Linh Dinh-Thi, Linh-Thuoc Tran, Yong-Suk Jang and Hieu Tran-Van*

Volume 26, Issue 9, 2019

Page: [676 - 683] Pages: 8

DOI: 10.2174/0929866526666190405122805

Price: $65


Background: The number of oral vaccines is still limited due to many difficulties suffered in the intestinal environment, such as mucosal clearance, vast area, harsh conditions, deteriorative enzymes, impermeability, tolerance, etc. Numerous strategies have focused on directing antigen to the receptors of M cells, which is the main gateway to acquire and initiate specific responses to antigens in intestine. FimHrb is a receptor binding domain of type 1 of fimbriae from E. coli and Salmonella that can bind to GP2 receptor expressed exclusively on M cells.

Objective: In this study, we evaluated the potential of FimHrb for oral vaccine development via its ability to adhere M cells.

Methods: The coding gene of FimHrb fused Green Fluorescent Protein (GFP) was cloned and expressed intracellularly in E. coli host strain. The recombinant protein FimHrb-GFP was then purified by IMAC method through 6x His tag designed downstream of GFP. Finally, the purified protein was monitored its binding on murine M cells in Payer Patch region.

Results: Following the methods mentioned above, the coding gene FimHrb-GFP was successfully cloned into vector pET22b and intracellularly expressed in soluble form at low temperature induction. The purity and the recovered yield of this protein were 90% and 20%, respectively. After that, the adhesion of FimHrb-GFP was monitored in murine small intestine, which showed that the protein bound to Peyer Patch region and did not restrict on M cells.

Conclusion: With the present data, we revealed a candidate protein FimHrb targeted receptor on M cells for oral vaccine development and other factors in E. coli would supplement FimH to provide the specific invasion of these bacteria via M cells.

Keywords: E. coli expression, FimH, low temperature induction, M cell, mucosal immunity, oral vaccines.

Graphical Abstract
Lycke, N. Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol., 2012, 12(8), 592-605.
[] [PMID: 22828912]
Silin, D.S.; Lyubomska, O.V.; Jirathitikal, V.; Bourinbaiar, A.S. Oral vaccination: where we are? Expert Opin. Drug Deliv., 2007, 4(4), 323-340.
[] [PMID: 17683247]
Garg, N.K.; Mangal, S.; Khambete, H.; Tyagi, R.K. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers. Recent Pat. Drug Deliv. Formul., 2010, 4(2), 114-128.
[] [PMID: 20380624]
Corr, S.C.; Gahan, C.C.; Hill, C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol. Med. Microbiol., 2008, 52(1), 2-12.
[] [PMID: 18081850]
Lo, D.D.; Ling, J.; Eckelhoefer, A.H. M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses. BMC Biotechnol., 2012, 12, 7.
[] [PMID: 22413871]
Hase, K.; Kawano, K.; Nochi, T.; Pontes, G.S.; Fukuda, S.; Ebisawa, M.; Kadokura, K.; Tobe, T.; Fujimura, Y.; Kawano, S.; Yabashi, A.; Waguri, S.; Nakato, G.; Kimura, S.; Murakami, T.; Hase, K.; Kawano, K.; Nochi, T.; Pontes, G.S.; Fukuda, S.; Ebisawa, M.; Kadokura, K.; Tobe, T.; Fujimura, Y.; Kawano, S.; Yabashi, A.; Waguri, S.; Nakato, G.; Kimura, S.; Murakami, T.; Iimura, M.; Hamura, K.; Fukuoka, S.; Lowe, A.W.; Itoh, K.; Kiyono, H.; Ohno, H. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature, 2009, 462(7270), 226-230.
[] [PMID: 19907495]
Asadi, K.M.; Oloomi, M.; Habibi, M.; Bouzari, S. Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran. Iran. J. Microbiol., 2012, 4(2), 55-62.
[PMID: 22973470]
Schembri, M.A.; Hasman, H.; Klemm, P. Expression and purification of the mannose recognition domain of the FimH adhesin. FEMS Microbiol. Lett., 2000, 188(2), 147-151.
[] [PMID: 10913698]
Knight, S.D.; Bouckaert, J. Structure, function, and assembly of type 1 fimbriae. Top. Curr. Chem., 2009, 288, 67-107.
[] [PMID: 22328027]
Kim, S.H.; Seo, K.W.; Kim, J.; Lee, K.Y.; Jang, Y.S. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J. Immunol., 2010, 185(10), 5787-5795.
[] [PMID: 20952686]
Kim, S.H.; Jang, Y.S. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp. Mol. Med, 2014, 46e85.
[] [PMID: 24626171]
Rabbani, S.; Jiang, X.; Schwardt, O.; Ernst, B. Expression of the carbohydrate recognition domain of FimH and development of a competitive binding assay. Anal. Biochem., 2010, 407(2), 188-195.
[] [PMID: 20705050]
Nguyen Thi Thanh Hoa, D.T.T. Hieu Tran, Van. Cloning and Expression of GFP-fused M cell targeting protein (FimH). In: The 2016 International Conference on Advanced technology and Sustainable development - International Symposium on Green technology 2016, Journal of Science and Technology Industrial University, 2016, vol. 23
Bornhorst, J.A.; Falke, J.J. Purification of proteins using polyhistidine affinity tags. Methods Enzymol., 2000, 326, 245-254.
[] [PMID: 11036646]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy